The CEO Perspective A No
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
This review consolidates the current understanding of these individual interventions and highlights the promising, yet under-explored, potential of their combined application in CRC management
Although studies in mice have shown that vitamin B-5 can reverse graying fur, there arent any clinical studies to show that such effects can happen in humans
Importantly to me, these medications are theorized to also exert mast cellstabilizing effects at these doses
(37552484) [3] Sustained-release formulations: Guidelines state that charcoal may be useful even after 4 hours if evidence of ongoing absorption is present, e.g., an increasing acetaminophen concentration. (37552484) For an ingestion that was slightly beyond four hours ago, it might be reasonable to empirically give activated charcoal (especially if there is a delayed turnaround time on serial acetaminophen levels)
